Search
astrocytic phosphoprotein PEA-15; 15 kD phosphoprotein enriched in astrocytes; phosphoprotein enriched in diabetes; PED (PEA15)
Function:
- blocks Ras-mediated inhibition of integrin activation & modulates the ERK MAP kinase cascade
- inhibits RPS6KA3
- activities by retaining it in the cytoplasm (putative)
- inhibits both TNFRSF6- & TNFRSF1A-mediated CASP8 activity & apoptosis
- regulates glucose transport by controlling both the content of SLC2A1 glucose transporters on the plasma membrane & the insulin-dependent trafficking of SLC2A4 from the cell interior to the surface
- phosphorylated by protein kinase C & CaM kinase
- phosphorylation is modulated by neurotransmitters or hormones
- binds RPS6KA3, MAPK3 & MAPK1
- transient interaction with PLD1 & PLD2 (putative)
- interacts with CASP8 & FADD
Structure: contains 1 DED (death effector) domain
Compartment:
- cytoplasm
- associated with microtubules
Expression:
- ubiquitously expressed
- most abundant in tissues such as heart, brain, muscle & adipose tissue which utilize glucose as an energy source
- lower expression in glucose-producing tissues
Pathology:
- higher levels of expression are found in tissues from individuals with type 2 diabetes than in controls
General
phosphoprotein
Properties
SIZE: entity length = 130 aa
MW = 15 kD
COMPARTMENT: cytoplasm
MOTIF: death effector domain {3-81}
MOTIF: Thr phosphorylation site {T6}
Ser phosphorylation site {S25}
Ser phosphorylation site {S61}
binding site
SITE: 98-107
FOR-BINDING-OF: microtubule
MOTIF: Ser phosphorylation site {S104}
Tyr phosphorylation site {Y108}
Ser phosphorylation site {S116}
binding site
SITE: 122-129
FOR-BINDING-OF: microtubule
Database Correlations
OMIM 603434
UniProt Q15121
Pfam PF01335
Entrez Gene 8682
Kegg hsa:8682
References
UniProt :accession Q15121